SubsidieMeestersFoundation Model-Based Biomarker Platform for Radiology and Clinical Trials
FoundRa aims to revolutionize radiology with an AI platform that accelerates precision medicine by generating scalable biomarkers and supporting radiologists in clinical trials and diagnostics.
Projectdetails
Introduction
The FoundRa project is based on two challenges:
- Due to aging and population growth, there is an increase in pathologies that require radiology, from diagnosis to follow-up.
- The ambition to make personalized medicine the standard of the future requires all kinds of biomarkers.
Company Overview
Raidium is an agile, young, and ambitious French company, born from the mission of the co-founders to accelerate the application of precision medicine and relieve radiologists from their enormous workload.
Product Offering
Raidium delivers the first scalable interactive AI platform for radiology, supporting radiologists in their work. This platform enables a broader group of clinicians to benefit from radiology insights and makes clinical trials faster and more cost-effective.
Innovation
The innovation is a multimodal foundation model (FM) that uses self-supervised learning based on unlabeled data, creating scalable biomarkers. Unlike current offerings, where biomarker-generating AI can only target one segment due to the time- and cost-consuming effort of supervised learning based on manually labeled data, Raidium's approach is more efficient.
Human-Centric Platform
The human-centric platform offers an intelligent interactive and intuitive human-machine interface that can be trained by the radiologist. It leverages their experience while performing automatic segmentation, annotation, and analytical tasks, providing reports and decision support.
Market Strategy
Radium's beachhead market is to be an AI-enabled contract research organization for pharmaceutical companies, providing strategic AI-generated biomarkers.
Ultimate Market
Radium's ultimate market is to provide an AI radiology platform as a Software as a Service (SaaS) to radiologists and clinical researchers in hospitals and pharma.
Future Plans
With the support from EIC, we will train our FM, integrate it into our platform, and accelerate the creation of AI-based biomarkers. This initiative aims to revolutionize and bring about significant advances in the fields of precision medicine in respect to medical practice and clinical trials.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.499.875 |
| Totale projectbegroting | € 2.499.875 |
Tijdlijn
| Startdatum | 1-11-2024 |
| Einddatum | 31-10-2026 |
| Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- RAIDIUMpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
An AI powered turn-key solution for MRI based interventional cardiologyNano4Imaging aims to deliver TRACKR, a B2B platform enhancing MRI-guided interventional radiology with nano-coatings and real-time tracking software for commercial device makers. | EIC Accelerator | € 2.482.709 | 2023 | Details |
AI-based clinical software for fully automated Cardiac Magnetic Resonance reportingAI4MedImaging is developing AI4CMR.Plus, a revolutionary software for automated cardiac assessment via CMR, aiming for a 2025 launch to enhance CVD diagnosis and improve patient outcomes. | EIC Accelerator | € 1.753.842 | 2022 | Details |
Accessible MRIThe AMRI project by CHIPIRON aims to develop an affordable, compact MRI scanner using ultra-low magnetic fields to enhance accessibility and diagnostic capabilities in underserved regions. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Miniaturised Respiratory Assist to treat acute lung failure patients using a breakthrough hyperbaric technologyHBOX Therapies aims to commercialize MiRA, a novel hyperoxygenation therapy for acute lung failure, enhancing patient outcomes while reducing reliance on invasive ventilation. | EIC Accelerator | € 2.499.999 | 2024 | Details |
The first IVDR-approved commercial software solutions for AI-powered RNA-based companion and precision cancer diagnostics of acute myeloid leukaemia and bladder cancerQlucore aims to revolutionize precision oncology by developing AI-driven diagnostic software for cancer, enhancing accuracy in gene analysis and improving survival rates across Europe. | EIC Accelerator | € 2.491.650 | 2024 | Details |
An AI powered turn-key solution for MRI based interventional cardiology
Nano4Imaging aims to deliver TRACKR, a B2B platform enhancing MRI-guided interventional radiology with nano-coatings and real-time tracking software for commercial device makers.
AI-based clinical software for fully automated Cardiac Magnetic Resonance reporting
AI4MedImaging is developing AI4CMR.Plus, a revolutionary software for automated cardiac assessment via CMR, aiming for a 2025 launch to enhance CVD diagnosis and improve patient outcomes.
Accessible MRI
The AMRI project by CHIPIRON aims to develop an affordable, compact MRI scanner using ultra-low magnetic fields to enhance accessibility and diagnostic capabilities in underserved regions.
Miniaturised Respiratory Assist to treat acute lung failure patients using a breakthrough hyperbaric technology
HBOX Therapies aims to commercialize MiRA, a novel hyperoxygenation therapy for acute lung failure, enhancing patient outcomes while reducing reliance on invasive ventilation.
The first IVDR-approved commercial software solutions for AI-powered RNA-based companion and precision cancer diagnostics of acute myeloid leukaemia and bladder cancer
Qlucore aims to revolutionize precision oncology by developing AI-driven diagnostic software for cancer, enhancing accuracy in gene analysis and improving survival rates across Europe.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Foundation models for molecular diagnostics - machine learning with biological ‘common sense’FoundationDX aims to enhance molecular diagnostics by using self-supervised learning on diverse biomolecular data to accurately predict cancer subtypes and treatment outcomes without extensive labeled datasets. | ERC Consolid... | € 2.000.000 | 2024 | Details |
Accurate quantification of neurologic disease over timeThe project aims to develop CHRONOS, an AI-driven diagnostic tool using synthetic biomaps to enable earlier and more accurate detection of brain tumors, facilitating timely clinical decisions. | ERC Proof of... | € 150.000 | 2025 | Details |
Cloud-IA: Een Cloud-based platformCloud-IA ontwikkelt een cloudplatform voor de integratie van AI-gedreven medische beeldverwerkingssoftware in ziekenhuizen, met als doel de diagnostische efficiëntie en kosteneffectiviteit te verbeteren. | Mkb-innovati... | € 326.297 | 2018 | Details |
Flexible and transparent platform based on oxide transistors for detection and readout of ionizing radiationFLETRAD aims to develop a flexible, transparent radiation sensing platform using oxide transistors, addressing market needs in healthcare and safety while enabling high-resolution detection. | ERC Proof of... | € 150.000 | 2022 | Details |
MIRACLE the platform for virtual biopsies; introducing Metabolic MRI-as-a-Service for oncologic careMIRACLE aims to develop a non-invasive MRI add-on for virtual biopsies, enabling personalized cancer treatment decisions by providing structural and metabolic tumor information globally. | EIC Transition | € 2.495.127 | 2022 | Details |
Foundation models for molecular diagnostics - machine learning with biological ‘common sense’
FoundationDX aims to enhance molecular diagnostics by using self-supervised learning on diverse biomolecular data to accurately predict cancer subtypes and treatment outcomes without extensive labeled datasets.
Accurate quantification of neurologic disease over time
The project aims to develop CHRONOS, an AI-driven diagnostic tool using synthetic biomaps to enable earlier and more accurate detection of brain tumors, facilitating timely clinical decisions.
Cloud-IA: Een Cloud-based platform
Cloud-IA ontwikkelt een cloudplatform voor de integratie van AI-gedreven medische beeldverwerkingssoftware in ziekenhuizen, met als doel de diagnostische efficiëntie en kosteneffectiviteit te verbeteren.
Flexible and transparent platform based on oxide transistors for detection and readout of ionizing radiation
FLETRAD aims to develop a flexible, transparent radiation sensing platform using oxide transistors, addressing market needs in healthcare and safety while enabling high-resolution detection.
MIRACLE the platform for virtual biopsies; introducing Metabolic MRI-as-a-Service for oncologic care
MIRACLE aims to develop a non-invasive MRI add-on for virtual biopsies, enabling personalized cancer treatment decisions by providing structural and metabolic tumor information globally.